openPR Logo
Press release

Uterine Fibroid Embolization Device Market Share Analysis, Trends And Forecast 2033

07-10-2024 10:18 AM CET | Health & Medicine

Press release from: The Business research company

Uterine Fibroid Embolization Device Market Share

Uterine Fibroid Embolization Device Market Share

The new report published by The Business Research Company, titled ""Uterine Fibroid Embolization Device Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the uterine fibroid embolization device market size has grown strongly in recent years. It will grow from $5.3 billion in 2023 to $5.62 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The uterine fibroid embolization device market size is expected to see steady growth in the next few years. It will grow to $6.75 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13551&type=smp

Minimally Invasive Surgery Driving Growth In Uterine Fibroid Embolization Device Market
The growing demand for minimally invasive surgeries is expected to propel the growth of the uterine fibroid embolization device market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient's body. Uterine fibroid embolization devices are essential tools that enable minimally invasive surgeries to treat uterine fibroids effectively. These specialized devices are meticulously designed to minimize invasiveness by using small incisions, reducing the impact on surrounding tissues. They cater to the increasing demand for less invasive medical procedures, ultimately improving patient outcomes. For instance, in January 2023, according to Intuitive Surgical Inc., a US-based technology corporation specializing in minimally invasive care products, in 2022, approximately 1,875,000 surgical procedures were performed with vinci surgical systems, an increase of approximately 18% compared with approximately 1,594,000 surgical procedures performed in 2021. Therefore, the growing demand for minimally invasive surgeries drives the growth of the uterine fibroid embolization device market.

Innovative Products Enhancing Minimally Invasive Treatment Of Uterine Fibroids
Major companies operating in the uterine fibroid embolization device market are developing innovative products such as the TruClear system to address the growing need for minimally invasive treatments for uterine fibroids and improve the safety and efficacy of treatment for uterine fibroids. The TruClear system is a mechanical hysteroscopic tissue removal system that is used to treat intrauterine abnormalities (IUA). It is a flexible catheter that is inserted into the uterus through the cervix. For instance, in November 2022, Medtronic Private Limited, an India-based industrial medical equipment manufacturer, launched the new TruClear system. This mechanical hysteroscopic tissue removal system treats intrauterine abnormalities (IUA). It is a safe and effective option for the treatment of IUA. Additionally, it is a compact, flexible catheter with a spinning nitinol wire loop, continuous inflow and outflow, integrated suction, and high-definition imaging, which contributes to improving the precision and safety of uterine fibroid treatment methods.

The uterine fibroid embolization device market covered in this report is segmented -

1) By Technology: Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques
2) By Mode Of Treatment: Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment
3) By End User: Hospitals, Clinics, Ambulatory Surgical Center

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13551&type=discount

Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd. , INSIGHTEC Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation

Contents of the report:
1. Executive Summary
2. Uterine Fibroid Embolization Device Market Report Structure
3. Uterine Fibroid Embolization Device Market Trends And Strategies
4. Uterine Fibroid Embolization Device Market - Macro Economic Scenario
5. Uterine Fibroid Embolization Device Market Size And Growth
…..
27. Uterine Fibroid Embolization Device Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/uterine-fibroid-embolization-device-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroid Embolization Device Market Share Analysis, Trends And Forecast 2033 here

News-ID: 3573914 • Views:

More Releases from The Business research company

In-Depth Examination of Segments, Industry Developments, and Key Competitors in the Commercial Aircraft Landing Gear Market
In-Depth Examination of Segments, Industry Developments, and Key Competitors in …
The commercial aircraft landing gear market is positioned for significant expansion over the coming years, driven by technological advancements and increasing air travel demands. As the aviation industry evolves, the landing gear segment is set to play a crucial role in supporting safer, more efficient aircraft operations. This overview explores the market's anticipated growth, key players, emerging trends, and essential segments shaping the future of commercial aircraft landing gear. Projected Growth
Key Players and Competitive Dynamics in the Cellular Vehicle-to-Everything (C-V2X) Roadside Unit Market
Key Players and Competitive Dynamics in the Cellular Vehicle-to-Everything (C-V2 …
The cellular vehicle-to-everything (C-V2X) roadside unit market is positioned for remarkable expansion over the coming years, driven by technological advancements and increasing infrastructure investments. This evolving sector is set to play a crucial role in shaping the future of connected transportation systems, integrating smart city concepts and autonomous vehicle technologies. Projected Market Size and Growth of the Cellular Vehicle-To-Everything (C-V2X) Roadside Unit Market The C-V2X roadside unit market is anticipated
Emerging Sub-Segments Transforming the Car Wheel Cap Market Landscape
Emerging Sub-Segments Transforming the Car Wheel Cap Market Landscape
The car wheel cap market is positioned for steady expansion over the coming years, reflecting evolving automotive trends and consumer preferences. With new material innovations and increasing demand for electric vehicles, this sector is expected to experience significant developments by 2030. Let's explore the market's growth potential, leading companies, key trends, and detailed segment analysis to better understand its trajectory. Projected Market Size and Growth Outlook for the Car Wheel Cap
Emerging Growth Patterns Driving Rapid Expansion in the Car Batteries Market
Emerging Growth Patterns Driving Rapid Expansion in the Car Batteries Market
The car batteries market is on track for steady expansion as electric vehicle adoption grows and battery technologies continue to improve. With increasing focus on sustainability and enhanced performance, this sector is set to experience significant development through the end of the decade. Below is a closer examination of the market size, key players, prevailing trends, and segment details shaping the future of car batteries. Projected Market Growth and Size of

All 5 Releases


More Releases for Uterine

Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic. Find out the best Fibroid Treatment for you! Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroi …
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms,
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape. Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort. According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to